Accendra Health (NYSE:ACH – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.04) earnings per share (EPS) for the quarter, FiscalAI reports. Accendra Health had a negative net margin of 23.32% and a negative return on equity of 50.04%. The business had revenue of $627.78 million during the quarter.
Accendra Health Stock Up 8.9%
ACH traded up $0.32 on Monday, reaching $3.90. The stock had a trading volume of 1,405,191 shares, compared to its average volume of 1,048,958. Accendra Health has a fifty-two week low of $1.84 and a fifty-two week high of $9.55. The stock has a market cap of $298.12 million, a PE ratio of -0.27, a PEG ratio of 2.91 and a beta of 1.70.
Analyst Ratings Changes
ACH has been the subject of a number of recent research reports. Weiss Ratings initiated coverage on Accendra Health in a report on Wednesday, April 8th. They issued a “sell (e+)” rating for the company. Zacks Research raised Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. One analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce”.
Institutional Investors Weigh In On Accendra Health
A number of institutional investors have recently made changes to their positions in the stock. Dimensional Fund Advisors LP bought a new stake in shares of Accendra Health in the 1st quarter valued at about $5,943,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Accendra Health in the 1st quarter valued at about $239,000. Bank of New York Mellon Corp bought a new stake in shares of Accendra Health in the 1st quarter valued at about $592,000. Hsbc Holdings PLC bought a new stake in shares of Accendra Health in the 1st quarter valued at about $34,000. Finally, Abel Hall LLC bought a new stake in shares of Accendra Health in the 1st quarter valued at about $44,000.
Accendra Health Company Profile
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.
See Also
- Five stocks we like better than Accendra Health
- MercadoLibre Boldly Invests in Growth: Discount Deepens
- AI Dividend Increases: 3 Massive Winners Boosting Payouts
- Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader
- 5 Stocks Positioned to Benefit From the AI Inference Boom
Receive News & Ratings for Accendra Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accendra Health and related companies with MarketBeat.com's FREE daily email newsletter.
